Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs
The DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Purpose To compare the effects of metformin with insulin on maternal and neonatal outcomes in gestational diabetes mellitus (GDM).Methods A literature search in PUBMED, EMBASE, Science Direct, Springer link, and Cochrane library was conducted using the following search terms: "Gestational Diabetes" or "GDM", and "insulin" and "metformin". Quality assessment of included studies was determined with Quality Assessment of Diagnostic Accuracy Studies. Review Manger 5.2 was used to analyze mean difference (MD)/risk ratio (RR) and 95 % confidence interval (CI) in random-effects model or fixed-effects model depending on the level of heterogeneity.Results A total of 11 studies were identified. There was no significant difference of the effect on maternal outcomes between the two treatments in glycohemoglobin A1c levels (P = 0.37), fasting blood glucose (P = 0.66), and the incidence of preeclampsia (P = 0.26); whereas, significantly reduced results were found in the metformin group in pregnancy-induced hypertension (PIH) rate (RR = 0.53, 95 % CI 0.31-0.90, P = 0.02), average weight gains after enrollment (MD = -1.28, 95 % CI -1.54 to -1.01, P < 0.0001), and average gestational ages at delivery (MD = 0.94, 95 % CI -0.21 to -0.01, P = 0.03). Regarding neonatal outcomes, when compared with insulin group, metformin presented significantly lower average birth weights (MD = -44.35, 95 % CI -85.79 to -2.90, P = 0.04), incidence of hypoglycemia (RR = 0.69, 95 % CI 0.55-0.87, P = 0.001) and neonatal intensive care unit (NICU) (RR = 0.82, 95 % CI 0.67-0.99, P = 0.04).Conclusion Metformin can significantly reduce several adverse maternal and neonatal outcomes including PIH rate, incidence of hypoglycemia and NICU, thus it may be an effective and safe alternative or additional treatment to insulin for GDM women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“recent meta-analyses have concluded that metformin is a safe alternative to insulin for pregnancy outcomes.2–6”
From Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age (2018) · cites this paper as [3]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 50 · Cited by 54
Metadata
- Authors
- Li, G., Zhao, S., Cui, S., Li, L., Xu, Y., & Li, Y.
- Affiliations
- Third Affiliated Hospital of Zhengzhou University (CN)
- Corresponding author
- Cui, Shihong
- Venue
- Archives of Gynecology and Obstetrics
- Published
- 2014-12-30
- Volume
- 292
- Issue
- 1
- Pages
- 111-120
- ISSN
- 0003-9128 (ISSN-L)
- 0932-0067
- 1432-0711
- OpenAlex
- W2062143126
- Cited by
- 54
- References
- 50
- Citations by year
- 2025: 5 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 2
- FWCI
- 0.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Gynecology and Obstetrics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- gestational diabetes mellitus, metformin, insulin therapy, maternal outcomes, neonatal outcomes, preeclampsia, gestational hypertension, birth weight, neonatal hypoglycemia, neonatal intensive care admission, fasting blood glucose, gestational weight gain, gestational age at delivery, antidiabetic drugs
- MeSH terms
- Birth Weight, Female, Gestational Age, Humans, Insulin, Metformin, Pre-Eclampsia, Pregnancy, Weight Gain, Randomized Controlled Trials as Topic, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. https://app.cochat.ai/papers/10.1007/s00404-014-3566-0
- The paper
- Li, G., Zhao, S., Cui, S., Li, L., Xu, Y., & Li, Y. (2015). Effect comparison of metformin with insulin treatment for gestational diabetes: a meta-analysis based on RCTs. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-014-3566-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.